These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
240 related items for PubMed ID: 23110545
1. Immunoglobulin E and mast cell proteases are potential risk factors of impaired fasting glucose and impaired glucose tolerance in humans. Wang Z, Zhang H, Shen XH, Jin KL, Ye GF, Qiu W, Qian L, Li B, Zhang YH, Shi GP. Ann Med; 2013 May; 45(3):220-9. PubMed ID: 23110545 [Abstract] [Full Text] [Related]
2. Immunoglobulin E and mast cell proteases are potential risk factors of human pre-diabetes and diabetes mellitus. Wang Z, Zhang H, Shen XH, Jin KL, Ye GF, Qian L, Li B, Zhang YH, Shi GP. PLoS One; 2011 May; 6(12):e28962. PubMed ID: 22194960 [Abstract] [Full Text] [Related]
3. Elevated level of C-reactive protein is associated with risk of prediabetes in Indians. Jaiswal A, Tabassum R, Podder A, Ghosh S, Tandon N, Bharadwaj D. Atherosclerosis; 2012 Jun; 222(2):495-501. PubMed ID: 22464286 [Abstract] [Full Text] [Related]
4. Impaired secretion of total glucagon-like peptide-1 in people with impaired fasting glucose combined impaired glucose tolerance. Zhang F, Tang X, Cao H, Lü Q, Li N, Liu Y, Zhang X, Zhang Y, Cao M, Wan J, An Z, Tong N. Int J Med Sci; 2012 Jun; 9(7):574-81. PubMed ID: 22991496 [Abstract] [Full Text] [Related]
5. Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action. Faerch K, Vaag A, Holst JJ, Glümer C, Pedersen O, Borch-Johnsen K. Diabetologia; 2008 May; 51(5):853-61. PubMed ID: 18317726 [Abstract] [Full Text] [Related]
6. Cardiovascular risk factors, carotid artery intima media thickness, and HSCRP levels in patients with impaired glucose metabolism. Karbek B, Cakal E, Cakir E, Bozkurt N, Unsal I, Sahin M, Delibaşi T. Minerva Endocrinol; 2013 Sep; 38(3):297-304. PubMed ID: 24126550 [Abstract] [Full Text] [Related]
7. Identical anthropometric characteristics of impaired fasting glucose combined with impaired glucose tolerance and newly diagnosed type 2 diabetes: anthropometric indicators to predict hyperglycaemia in a community-based prospective cohort study in southwest China. Zhang F, Wan Q, Cao H, Tang L, Li D, Lü Q, Yan Z, Li J, Yang Q, Zhang Y, Tong N. BMJ Open; 2018 May 09; 8(5):e019735. PubMed ID: 29743321 [Abstract] [Full Text] [Related]
8. Natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance: the Inter99 study. Faerch K, Vaag A, Holst JJ, Hansen T, Jørgensen T, Borch-Johnsen K. Diabetes Care; 2009 Mar 09; 32(3):439-44. PubMed ID: 19056613 [Abstract] [Full Text] [Related]
9. Comparison of Insulin Resistance and β-Cell Dysfunction Between the Young and the Elderly in Normal Glucose Tolerance and Prediabetes Population: A Prospective Study. Chen G, Shi L, Cai L, Lin W, Huang H, Liang J, Li L, Lin L, Tang K, Chen L, Lu J, Bi Y, Wang W, Ning G, Wen J. Horm Metab Res; 2017 Feb 09; 49(2):135-141. PubMed ID: 27459384 [Abstract] [Full Text] [Related]
10. Serum lipid and hsCRP levels in prediabetes--impaired fasting glucose (IFG) and impaired glucose tolerance (IGT). Chakarova N, Tankova T, Atanassova I, Dakovska L. Diabetes Res Clin Pract; 2009 Oct 09; 86(1):56-60. PubMed ID: 19674805 [Abstract] [Full Text] [Related]
11. Fasting, non-fasting glucose and HDL dysfunction in risk of pre-diabetes, diabetes, and coronary disease in non-diabetic adults. Onat A, Can G, Çiçek G, Ayhan E, Doğan Y, Kaya H. Acta Diabetol; 2013 Aug 09; 50(4):519-28. PubMed ID: 21769500 [Abstract] [Full Text] [Related]
12. Pre-diabetes in Italian obese children and youngsters. Brufani C, Fintini D, Ciampalini P, Nocerino V, Crea F, Giannone G, Patera PI, Valerio G, Cappa M, Barbetti F. J Endocrinol Invest; 2011 Oct 09; 34(9):e275-80. PubMed ID: 21666412 [Abstract] [Full Text] [Related]
13. Progression from optimal blood glucose and pre-diabetes to type 2 diabetes in a high risk population with or without hypertension in Isfahan, Iran. Janghorbani M, Amini M. Diabetes Res Clin Pract; 2015 Jun 09; 108(3):414-22. PubMed ID: 25814432 [Abstract] [Full Text] [Related]
14. Insulin resistance, beta-cell function, adipokine profiles and cardiometabolic risk factors among Chinese youth with isolated impaired fasting glucose versus impaired glucose tolerance: the BCAMS study. Li Y, Feng D, Esangbedo IC, Zhao Y, Han L, Zhu Y, Fu J, Li G, Wang D, Wang Y, Li M, Gao S, Willi SM. BMJ Open Diabetes Res Care; 2020 Feb 09; 8(1):. PubMed ID: 32049638 [Abstract] [Full Text] [Related]
15. Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose. Kanat M, Norton L, Winnier D, Jenkinson C, DeFronzo RA, Abdul-Ghani MA. Acta Diabetol; 2011 Sep 09; 48(3):209-17. PubMed ID: 21553243 [Abstract] [Full Text] [Related]
16. Associations between GDF15 levels and pre-diabetes in non-obese subjects. Hung HC, Wu HT, Lin CH, Chou HW, Ou HY, Chang CJ. J Investig Med; 2022 Jan 09; 70(1):79-84. PubMed ID: 34376526 [Abstract] [Full Text] [Related]
17. Increased visceral fat and impaired glucose tolerance predict the increased risk of metabolic syndrome in Japanese middle-aged men. Mori Y, Hoshino K, Yokota K, Yokose T, Tajima N. Exp Clin Endocrinol Diabetes; 2005 Jun 09; 113(6):334-9. PubMed ID: 15977101 [Abstract] [Full Text] [Related]
18. Insulin secretion and sensitivity in Bangladeshi prediabetic subjects. Rahman MH, Hafizur RM, Nahar Q, Khan AR, Ali L. J Diabetes Complications; 2010 Jun 09; 24(1):37-42. PubMed ID: 19010062 [Abstract] [Full Text] [Related]